mRNA Vaccine and Therapeutics Raw Material Market
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of mRNA Vaccine and Therapeutics Raw Material
1.2 Key Market Segments
1.2.1 mRNA Vaccine and Therapeutics Raw Material Segment by Type
1.2.2 mRNA Vaccine and Therapeutics Raw Material Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 mRNA Vaccine and Therapeutics Raw Material Market Overview
2.1 Global Market Overview
2.1.1 Global mRNA Vaccine and Therapeutics Raw Material Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global mRNA Vaccine and Therapeutics Raw Material Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 mRNA Vaccine and Therapeutics Raw Material Market Competitive Landscape
3.1 Global mRNA Vaccine and Therapeutics Raw Material Sales by Manufacturers (2019-2024)
3.2 Global mRNA Vaccine and Therapeutics Raw Material Revenue Market Share by Manufacturers (2019-2024)
3.3 mRNA Vaccine and Therapeutics Raw Material Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global mRNA Vaccine and Therapeutics Raw Material Average Price by Manufacturers (2019-2024)
3.5 Manufacturers mRNA Vaccine and Therapeutics Raw Material Sales Sites, Area Served, Product Type
3.6 mRNA Vaccine and Therapeutics Raw Material Market Competitive Situation and Trends
3.6.1 mRNA Vaccine and Therapeutics Raw Material Market Concentration Rate
3.6.2 Global 5 and 10 Largest mRNA Vaccine and Therapeutics Raw Material Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 mRNA Vaccine and Therapeutics Raw Material Industry Chain Analysis
4.1 mRNA Vaccine and Therapeutics Raw Material Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of mRNA Vaccine and Therapeutics Raw Material Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 mRNA Vaccine and Therapeutics Raw Material Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Type (2019-2024)
6.3 Global mRNA Vaccine and Therapeutics Raw Material Market Size Market Share by Type (2019-2024)
6.4 Global mRNA Vaccine and Therapeutics Raw Material Price by Type (2019-2024)
7 mRNA Vaccine and Therapeutics Raw Material Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global mRNA Vaccine and Therapeutics Raw Material Market Sales by Application (2019-2024)
7.3 Global mRNA Vaccine and Therapeutics Raw Material Market Size (M USD) by Application (2019-2024)
7.4 Global mRNA Vaccine and Therapeutics Raw Material Sales Growth Rate by Application (2019-2024)
8 mRNA Vaccine and Therapeutics Raw Material Market Segmentation by Region
8.1 Global mRNA Vaccine and Therapeutics Raw Material Sales by Region
8.1.1 Global mRNA Vaccine and Therapeutics Raw Material Sales by Region
8.1.2 Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Region
8.2 North America
8.2.1 North America mRNA Vaccine and Therapeutics Raw Material Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe mRNA Vaccine and Therapeutics Raw Material Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific mRNA Vaccine and Therapeutics Raw Material Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America mRNA Vaccine and Therapeutics Raw Material Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa mRNA Vaccine and Therapeutics Raw Material Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Jena Bioscience
9.1.1 Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Basic Information
9.1.2 Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Product Overview
9.1.3 Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.1.4 Jena Bioscience Business Overview
9.1.5 Jena Bioscience mRNA Vaccine and Therapeutics Raw Material SWOT Analysis
9.1.6 Jena Bioscience Recent Developments
9.2 Thermo Fisher Scientific Inc.
9.2.1 Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Basic Information
9.2.2 Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Product Overview
9.2.3 Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.2.4 Thermo Fisher Scientific Inc. Business Overview
9.2.5 Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material SWOT Analysis
9.2.6 Thermo Fisher Scientific Inc. Recent Developments
9.3 SBS Genetech
9.3.1 SBS Genetech mRNA Vaccine and Therapeutics Raw Material Basic Information
9.3.2 SBS Genetech mRNA Vaccine and Therapeutics Raw Material Product Overview
9.3.3 SBS Genetech mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.3.4 SBS Genetech mRNA Vaccine and Therapeutics Raw Material SWOT Analysis
9.3.5 SBS Genetech Business Overview
9.3.6 SBS Genetech Recent Developments
9.4 Sigma Aldrich
9.4.1 Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Basic Information
9.4.2 Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Product Overview
9.4.3 Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.4.4 Sigma Aldrich Business Overview
9.4.5 Sigma Aldrich Recent Developments
9.5 Moderna Therapeutics
9.5.1 Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Basic Information
9.5.2 Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Overview
9.5.3 Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.5.4 Moderna Therapeutics Business Overview
9.5.5 Moderna Therapeutics Recent Developments
9.6 CureVac
9.6.1 CureVac mRNA Vaccine and Therapeutics Raw Material Basic Information
9.6.2 CureVac mRNA Vaccine and Therapeutics Raw Material Product Overview
9.6.3 CureVac mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.6.4 CureVac Business Overview
9.6.5 CureVac Recent Developments
9.7 Translate Bio
9.7.1 Translate Bio mRNA Vaccine and Therapeutics Raw Material Basic Information
9.7.2 Translate Bio mRNA Vaccine and Therapeutics Raw Material Product Overview
9.7.3 Translate Bio mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.7.4 Translate Bio Business Overview
9.7.5 Translate Bio Recent Developments
9.8 BioNTech
9.8.1 BioNTech mRNA Vaccine and Therapeutics Raw Material Basic Information
9.8.2 BioNTech mRNA Vaccine and Therapeutics Raw Material Product Overview
9.8.3 BioNTech mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.8.4 BioNTech Business Overview
9.8.5 BioNTech Recent Developments
9.9 Sangamo Therapeutics
9.9.1 Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Basic Information
9.9.2 Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Overview
9.9.3 Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.9.4 Sangamo Therapeutics Business Overview
9.9.5 Sangamo Therapeutics Recent Developments
9.10 Argos Therapeutics
9.10.1 Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Basic Information
9.10.2 Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Overview
9.10.3 Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.10.4 Argos Therapeutics Business Overview
9.10.5 Argos Therapeutics Recent Developments
9.11 In-Cell-Art
9.11.1 In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Basic Information
9.11.2 In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Product Overview
9.11.3 In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.11.4 In-Cell-Art Business Overview
9.11.5 In-Cell-Art Recent Developments
9.12 Etherna
9.12.1 Etherna mRNA Vaccine and Therapeutics Raw Material Basic Information
9.12.2 Etherna mRNA Vaccine and Therapeutics Raw Material Product Overview
9.12.3 Etherna mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.12.4 Etherna Business Overview
9.12.5 Etherna Recent Developments
9.13 Ethris
9.13.1 Ethris mRNA Vaccine and Therapeutics Raw Material Basic Information
9.13.2 Ethris mRNA Vaccine and Therapeutics Raw Material Product Overview
9.13.3 Ethris mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.13.4 Ethris Business Overview
9.13.5 Ethris Recent Developments
9.14 Tiba Biotechnology
9.14.1 Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Basic Information
9.14.2 Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Product Overview
9.14.3 Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.14.4 Tiba Biotechnology Business Overview
9.14.5 Tiba Biotechnology Recent Developments
9.15 Product Type Insights
9.15.1 Product Type Insights mRNA Vaccine and Therapeutics Raw Material Basic Information
9.15.2 Product Type Insights mRNA Vaccine and Therapeutics Raw Material Product Overview
9.15.3 Product Type Insights mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.15.4 Product Type Insights Business Overview
9.15.5 Product Type Insights Recent Developments
10 mRNA Vaccine and Therapeutics Raw Material Market Forecast by Region
10.1 Global mRNA Vaccine and Therapeutics Raw Material Market Size Forecast
10.2 Global mRNA Vaccine and Therapeutics Raw Material Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Country
10.2.3 Asia Pacific mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Region
10.2.4 South America mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of mRNA Vaccine and Therapeutics Raw Material by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global mRNA Vaccine and Therapeutics Raw Material Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of mRNA Vaccine and Therapeutics Raw Material by Type (2025-2030)
11.1.2 Global mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of mRNA Vaccine and Therapeutics Raw Material by Type (2025-2030)
11.2 Global mRNA Vaccine and Therapeutics Raw Material Market Forecast by Application (2025-2030)
11.2.1 Global mRNA Vaccine and Therapeutics Raw Material Sales (Kilotons) Forecast by Application
11.2.2 Global mRNA Vaccine and Therapeutics Raw Material Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. mRNA Vaccine and Therapeutics Raw Material Market Size Comparison by Region (M USD)
Table 5. Global mRNA Vaccine and Therapeutics Raw Material Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Manufacturers (2019-2024)
Table 7. Global mRNA Vaccine and Therapeutics Raw Material Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global mRNA Vaccine and Therapeutics Raw Material Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccine and Therapeutics Raw Material as of 2022)
Table 10. Global Market mRNA Vaccine and Therapeutics Raw Material Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers mRNA Vaccine and Therapeutics Raw Material Sales Sites and Area Served
Table 12. Manufacturers mRNA Vaccine and Therapeutics Raw Material Product Type
Table 13. Global mRNA Vaccine and Therapeutics Raw Material Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of mRNA Vaccine and Therapeutics Raw Material
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. mRNA Vaccine and Therapeutics Raw Material Market Challenges
Table 22. Global mRNA Vaccine and Therapeutics Raw Material Sales by Type (Kilotons)
Table 23. Global mRNA Vaccine and Therapeutics Raw Material Market Size by Type (M USD)
Table 24. Global mRNA Vaccine and Therapeutics Raw Material Sales (Kilotons) by Type (2019-2024)
Table 25. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Type (2019-2024)
Table 26. Global mRNA Vaccine and Therapeutics Raw Material Market Size (M USD) by Type (2019-2024)
Table 27. Global mRNA Vaccine and Therapeutics Raw Material Market Size Share by Type (2019-2024)
Table 28. Global mRNA Vaccine and Therapeutics Raw Material Price (USD/Ton) by Type (2019-2024)
Table 29. Global mRNA Vaccine and Therapeutics Raw Material Sales (Kilotons) by Application
Table 30. Global mRNA Vaccine and Therapeutics Raw Material Market Size by Application
Table 31. Global mRNA Vaccine and Therapeutics Raw Material Sales by Application (2019-2024) & (Kilotons)
Table 32. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Application (2019-2024)
Table 33. Global mRNA Vaccine and Therapeutics Raw Material Sales by Application (2019-2024) & (M USD)
Table 34. Global mRNA Vaccine and Therapeutics Raw Material Market Share by Application (2019-2024)
Table 35. Global mRNA Vaccine and Therapeutics Raw Material Sales Growth Rate by Application (2019-2024)
Table 36. Global mRNA Vaccine and Therapeutics Raw Material Sales by Region (2019-2024) & (Kilotons)
Table 37. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Region (2019-2024)
Table 38. North America mRNA Vaccine and Therapeutics Raw Material Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe mRNA Vaccine and Therapeutics Raw Material Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific mRNA Vaccine and Therapeutics Raw Material Sales by Region (2019-2024) & (Kilotons)
Table 41. South America mRNA Vaccine and Therapeutics Raw Material Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa mRNA Vaccine and Therapeutics Raw Material Sales by Region (2019-2024) & (Kilotons)
Table 43. Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Basic Information
Table 44. Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 45. Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Jena Bioscience Business Overview
Table 47. Jena Bioscience mRNA Vaccine and Therapeutics Raw Material SWOT Analysis
Table 48. Jena Bioscience Recent Developments
Table 49. Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Basic Information
Table 50. Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 51. Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Thermo Fisher Scientific Inc. Business Overview
Table 53. Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material SWOT Analysis
Table 54. Thermo Fisher Scientific Inc. Recent Developments
Table 55. SBS Genetech mRNA Vaccine and Therapeutics Raw Material Basic Information
Table 56. SBS Genetech mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 57. SBS Genetech mRNA Vaccine and Therapeutics Raw Material Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. SBS Genetech mRNA Vaccine and Therapeutics Raw Material SWOT Analysis
Table 59. SBS Genetech Business Overview
Table 60. SBS Genetech Recent Developments
Table 61. Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Basic Information
Table 62. Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 63. Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Sigma Aldrich Business Overview
Table 65. Sigma Aldrich Recent Developments
Table 66. Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Basic Information
Table 67. Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 68. Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Moderna Therapeutics Business Overview
Table 70. Moderna Therapeutics Recent Developments
Table 71. CureVac mRNA Vaccine and Therapeutics Raw Material Basic Information
Table 72. CureVac mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 73. CureVac mRNA Vaccine and Therapeutics Raw Material Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. CureVac Business Overview
Table 75. CureVac Recent Developments
Table 76. Translate Bio mRNA Vaccine and Therapeutics Raw Material Basic Information
Table 77. Translate Bio mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 78. Translate Bio mRNA Vaccine and Therapeutics Raw Material Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Translate Bio Business Overview
Table 80. Translate Bio Recent Developments
Table 81. BioNTech mRNA Vaccine and Therapeutics Raw Material Basic Information
Table 82. BioNTech mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 83. BioNTech mRNA Vaccine and Therapeutics Raw Material Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. BioNTech Business Overview
Table 85. BioNTech Recent Developments
Table 86. Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Basic Information
Table 87. Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 88. Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Sangamo Therapeutics Business Overview
Table 90. Sangamo Therapeutics Recent Developments
Table 91. Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Basic Information
Table 92. Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 93. Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Argos Therapeutics Business Overview
Table 95. Argos Therapeutics Recent Developments
Table 96. In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Basic Information
Table 97. In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 98. In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. In-Cell-Art Business Overview
Table 100. In-Cell-Art Recent Developments
Table 101. Etherna mRNA Vaccine and Therapeutics Raw Material Basic Information
Table 102. Etherna mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 103. Etherna mRNA Vaccine and Therapeutics Raw Material Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Etherna Business Overview
Table 105. Etherna Recent Developments
Table 106. Ethris mRNA Vaccine and Therapeutics Raw Material Basic Information
Table 107. Ethris mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 108. Ethris mRNA Vaccine and Therapeutics Raw Material Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Ethris Business Overview
Table 110. Ethris Recent Developments
Table 111. Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Basic Information
Table 112. Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 113. Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Tiba Biotechnology Business Overview
Table 115. Tiba Biotechnology Recent Developments
Table 116. Product Type Insights mRNA Vaccine and Therapeutics Raw Material Basic Information
Table 117. Product Type Insights mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 118. Product Type Insights mRNA Vaccine and Therapeutics Raw Material Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Product Type Insights Business Overview
Table 120. Product Type Insights Recent Developments
Table 121. Global mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa mRNA Vaccine and Therapeutics Raw Material Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global mRNA Vaccine and Therapeutics Raw Material Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global mRNA Vaccine and Therapeutics Raw Material Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of mRNA Vaccine and Therapeutics Raw Material
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global mRNA Vaccine and Therapeutics Raw Material Market Size (M USD), 2019-2030
Figure 5. Global mRNA Vaccine and Therapeutics Raw Material Market Size (M USD) (2019-2030)
Figure 6. Global mRNA Vaccine and Therapeutics Raw Material Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. mRNA Vaccine and Therapeutics Raw Material Market Size by Country (M USD)
Figure 11. mRNA Vaccine and Therapeutics Raw Material Sales Share by Manufacturers in 2023
Figure 12. Global mRNA Vaccine and Therapeutics Raw Material Revenue Share by Manufacturers in 2023
Figure 13. mRNA Vaccine and Therapeutics Raw Material Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market mRNA Vaccine and Therapeutics Raw Material Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by mRNA Vaccine and Therapeutics Raw Material Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global mRNA Vaccine and Therapeutics Raw Material Market Share by Type
Figure 18. Sales Market Share of mRNA Vaccine and Therapeutics Raw Material by Type (2019-2024)
Figure 19. Sales Market Share of mRNA Vaccine and Therapeutics Raw Material by Type in 2023
Figure 20. Market Size Share of mRNA Vaccine and Therapeutics Raw Material by Type (2019-2024)
Figure 21. Market Size Market Share of mRNA Vaccine and Therapeutics Raw Material by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global mRNA Vaccine and Therapeutics Raw Material Market Share by Application
Figure 24. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Application (2019-2024)
Figure 25. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Application in 2023
Figure 26. Global mRNA Vaccine and Therapeutics Raw Material Market Share by Application (2019-2024)
Figure 27. Global mRNA Vaccine and Therapeutics Raw Material Market Share by Application in 2023
Figure 28. Global mRNA Vaccine and Therapeutics Raw Material Sales Growth Rate by Application (2019-2024)
Figure 29. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Region (2019-2024)
Figure 30. North America mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Country in 2023
Figure 32. U.S. mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada mRNA Vaccine and Therapeutics Raw Material Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico mRNA Vaccine and Therapeutics Raw Material Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Country in 2023
Figure 37. Germany mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Region in 2023
Figure 44. China mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (Kilotons)
Figure 50. South America mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Country in 2023
Figure 51. Brazil mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Region in 2023
Figure 56. Saudi Arabia mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global mRNA Vaccine and Therapeutics Raw Material Market Share Forecast by Type (2025-2030)
Figure 65. Global mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Application (2025-2030)
Figure 66. Global mRNA Vaccine and Therapeutics Raw Material Market Share Forecast by Application (2025-2030)
